1,443
Views
32
CrossRef citations to date
0
Altmetric
ACTA ONCOLOGICA LECTURE

Insights into a complex group of neoplastic disease: Advances in histopathologic classification and molecular pathology of salivary gland cancer

Pages 662-668 | Received 09 May 2006, Published online: 08 Jul 2009

References

  • Seifert G. World Health Organization international histological classification of tumours: Histological typing of salivary gland tumours2nd ed. Springer, Berlin, Heidelberg, New York 1991
  • Barnes L, Eveson JW, Reichart P, Sidransky D. Pathology and genetics of head and neck tumours. World Health Organization Classification of Tumours. IARC Press, Lyon 2005; 1–430
  • Luukkaa H, Klemi P, Leivo I, Koivunen P, Laranne J, Makitie A, et al. Salivary gland cancer in Finland 1991–96: An evaluation of 237 cases. Acta Otolaryngol 2005; 125: 207–14
  • Seifert G. Mucoepidermoid carcinoma in a salivary duct cyst of the parotid gland: Contribution to the development of tumours in salivary gland cysts. Pathol Res Pract 1996; 192: 1211–7
  • Handra-Luca A, Lamas G, Bertrand JC, Fouret P. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: Diagnostic and prognostic implications. Am J Surg Pathol 2005; 29: 881–9
  • Foschini M, Scarpellini F, Gown AM, Eusebi V. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 2000; 8: 29–37
  • Enlund F, Behboudi A, Andrén Y, Öberg C, Lendahl C, Mark J, et al. Altered Notch signaling resulting from expression of a WAMP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin′s tumors. Exp Cell Res 2004; 292: 21–8
  • Martins C, Cavaco B, Tonon G, Kaye FJ, Soares J, Fonseca I. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn 2004; 6: 205–10
  • Behboudi A, Enlund F, Winnes M, Andren Y, Nordkvist A, Leivo I, et al. Molecular classification of mucoepidermoid carcinomas-Prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 2006; 45: 470–81
  • Goode RK, Auclair PL, Ellis AL. Mucoepidermoid carcinoma of the major salivary glands: Clinical and histologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998; 82: 1217–24
  • Ellis GL, Auclair PL. Malignant epithelial tumors. In: Atlas of tumor pathology, 3rd series, fascicle 17: Tumors of the salivary glands Washington DC: AFIP; 1996.
  • Brandwein MS, Ivanov K, Wallace DI, Hille JJ, Wang B, Fahmy A, et al. Mucoepidermoid carcinoma: A clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol 2001; 25: 835–45
  • Skálová A, Lehtonen H, von Boguslawsky K, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinoma of the salivary gland: Clinicopathological study using MIB1 antibody in paraffin sections. Hum Pathol 1994; 25: 929–35
  • Heikinheimo AK, Laine MA, Ritvos OV, Voutilainen RJ, Hogan BLM, Leivo IV. Bone morphogenetic protein-6 is a marker of serous acinar cell differentiation in normal and neoplastic human salivary gland. Cancer Res 1999; 59: 5815–21
  • Skálová A, Leivo I, von Boguslawsky K, Saksela E. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB1 antibody in formalin-fixed paraffin sections. J Pathol 1994; 173: 13–21
  • Hellquist HB, Sundelin K, Di Bacco A, Tytor M, Manzotti M, Viale G. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). J Pathol 1997; 181: 323–9
  • Brandwein MS, Jagirdar J, Patil J, Biller H, Kaneko M. Salivary duct carcinoma (cribriform salivary carcinoma of excretory ducts): A clinicopathologic and immunohistochemical study of 12 cases. Cancer 1990; 65: 2307–14
  • Henley JD, Seo IS, Dayan D, Gnepp DR. Sarcomatoid salivary duct carcinoma of the parotid gland. Hum Pathol 2000; 31: 208–13
  • Simpson RHW, Prasad A, Lewis JE, Skálová A, David L. Mucin-rich variant of salivary duct carcinoma: A clinicopathological study of four cases. Am J Surg Pathol 2003; 27: 1070–9
  • Nagao T, Gaffey TA, Visscher DW, Kay PA, Minato H, Serizawa H. Invasive micropapillary salivary duct carcinoma: A distinct histologic variant with biologic significance. Am J Surg Pathol 2004; 28: 319–26
  • Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M. Salivary duct carcinoma: Cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer (Cancer Cytopathol) 2001; 93: 344–50
  • Skálová A, Starek I, Vanecek T, Kucerova V, Plank L, Szepe P, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by immunofluorescence in situ hybridization and immunohistochemistry. Histopathology 2003; 42: 1–9
  • Brandwein-Gensler M, Hille J, Wang BY, Urken M, Gordon R, Wang LJ, et al. Low-grade salivary duct carcinoma: Description of 16 cases. Am J Surg Pathol 2004; 28: 1040–4
  • Nagao K, Matsuzaki O, Saiga H, Sugano I, Shigematsu H, Kaneko T, et al. Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland. Cancer 1981; 48: 113–21
  • Di Palma S, Pilotti S, Rilke F. Malignant myoepithelioma of the parotid arising in a pleomorphic adenoma. Histopathology 1991; 19: 273–5
  • Alós LL, Cardesa A, Bombí JA, Mallofré C, Cuchi A, Traserra J. Myoepithelial tumors of salivary glands: A clinicopathologic, immunohistochemical and flow-cytometric study. Semin Diagn Pathol 1996; 13: 138–47
  • Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands: A clinicopathologic study of 25 patients. Am J Surg Pathol 2000; 24: 761–74
  • Reis-Filho JS, Simpson RHW, Fulford LG, Steppeler Y, Martins A, Schmitt FC. p63 distribution in normal salivary gland and salivary gland neoplasms (Abstract). Mod Pathol 2004; 17: 231A
  • Nagao T, Sugano I, Ishida Y, Tajima Y, Matsuzaki O, Konno A, et al. Salivary gland malignant myoepithelioma: A clinicopathologic and immunohistochemical study of ten cases. Cancer 1998; 83: 1292–9
  • Skálová A, Simpson RHW, Lehtonen H, Leivo I. Assessment of proliferative activity using the MIB1 antibody helps to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands. Pathol Res Pract 1997; 193: 695–703
  • Evans HL, Luna MA. Polymorphous low-grade adenocarcinoma: A study of 40 cases with long-term follow up and evaluation of the importance of papillary areas. Am J Surg Pathol 2000; 24: 1319–28
  • Parrett TJ, Prasad AR, Raslan WF, Kakar S, Lewis JE. Long term and life-long follow-up in polymorphous low grade adenocarcinoma (Abstract). Mod Pathol 2002; 15: 223A
  • Michal M, Skálová A, Simpson RHW, Raslan WF, Čuřík R, Leivo I, et al. Cribriform adenocarcinoma of the tongue: A hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology 1999; 35: 495–501
  • Milchgrub S, Gnepp DR, Vuitch F, Delgado R, Albores-Saavedra J. Hyalinizing clear cell carcinoma of the salivary gland. Am J Surg Pathol 1994; 18: 74–82
  • Frierson HF, El-Naggar AK, Welsh JB, Sapinoso LM, Su AI, Cheng J, et al. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. Am J Surg Pathol 2002; 161: 1315–23
  • Stallmach I, Zenklusen P, Komminoth P, Schmid S, Perren A, Roos M, et al. Loss of heterozygosity at chromosome 6q23-25 correlates with clinical and histologic parameters in salivary gland adenoid cystic carcinoma. Virchows Arch 2002; 440: 77–84
  • Leivo I, Jee KJ, Heikinheimo K, Laine M, Ollila J, Nagy B, et al. Characterization of gene expression in major types of salivary gland carcinoma with epithelial differentiation. Cancer Genet Cytogenet 2005; 156: 104–13
  • Gibbons MD, Manne U, Carroll WR, Peters GE, Weiss HL, Grizzle WE. Molecular differences in mucoepidermoid carcinoma and adenoid cystic carcinoma of the major salivary glands. Laryngoscope 2001; 111: 1373–8
  • Rutherford S, Hampton GM, Frierson HF, Moskaluk CA. Mapping of candidate tumor suppressor genes on chromosome 12 in adenoid cystic carcinomas. Lab Invest 2005; 85: 1076–85
  • Rutherford S, Yu Y, Rumpel CA, Frierson HF, Jr, Moskaluk CA. Chromosome 6 deletion and candidate tumor suppressor genes in adenoid cystic carcinoma. Cancer Lett 2005;Jul 27 (Epub ahead of print).
  • Freier K, Flechtenmacher C, Walch A, Ohl S, Devens F, Burke B, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 2005; 159: 89–95
  • Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003; 33: 208–13
  • Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, et al. Mect1Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 2005; 65: 7137–44
  • Kishi M, Nakamura M, Nishimine M, Ikuta M, Kirita T, Konishi N. Genetic and epigenetic alteration profiles for multiple genes in salivary gland carcinomas. Oral Oncol 2005; 41: 161–9
  • Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B, Stamp G, et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002; 21: 4587–94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.